Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).
Paul Colussi
Advertisement
Paul Colussi is the head of protein expression at Tetragenetics Inc
Articles by Paul Colussi
Advertisement
Latest Updated Articles
Advertisement
Advertisement